Medical Science Liaison - Rare Disease - Central West US

Company: myGwork
Location: Denver
Posted on: January 27, 2023

Job Description:

Medical Science Liaison (MSL) - Central West US The Medical Science Liaison (MSL) will be responsible for providing non-promotional scientific, educational, and research support for the Genzyme Rare Disease portfolio in the respective territory. The MSL will be responsible for developing and maintaining relationships with key Rare Disease experts and building a well-informed advocacy base for Sanofi Genzyme's Rare Disease franchise, including compounds in the development program. The MSL will act as a conduit for providing accurate and updated clinical, scientific and medical information to Rare Disease Experts, health care professionals, treatments decision makers and other members of the scientific, provider and payer community (private insurance, payers, medical groups, government agencies, and health systems with drug formularies), in compliance with all relevant company policies. This territory is based in Central West states, covering Colorado, Utah, Wyoming, Montana, Nebraska, North and South Dakota, Kansas, and Iowa. MSL coverage of the territory will require 50-60% travel. The Mis s ion o f S a nofi's MSL Te a m and the Medic a l S c i en c e Liai s on is to be the tr u st e d s c ientific partne r s in the field f or e x te r nal e x perts and de c ision - m a ke r s engaging in mu t ual s c ientific e x changes to a c cel e r a t e data dis s e m ination. S a no f i's Medic a l Field b a se teams en h an c e the under s tanding of t he s c ientific and m e dic a l v alue of our products in t he ther a peutic area and gather n e w i ns i ghts by b ringing cutt i ng e d ge s c ientific e x ch a nge today that a c celer a tes m edic a l inn o v ation to m orr o w The M edi c al Sc i ence Lia i son (MS L ) is fiel d -fac i ng ro le wh o se m a i n obj e ctives a re t o: Be the trust e d scienti f ic p artn e r to key ex t ernal ex p erts by con d ucting ti m ely, appropr i ate, and frequent sci e nti f ic exc h an g es to e nh a nce the u n ders t anding of the s c i enti f ic a nd medical value of our p ro d uc t s . E x ecute on s t ake h old e r e ngagement p lans to gath e r data, deve l op a n d sha r e medical i n s i ghts that contri b ute to enha n cement of S an o fi ' s key med i cal messa g es, plans a nd f uture r esea r c h . Keep abr e a st of med i cal a n d scientif i c d e velop m en t s i n the thera pe utic field t o h elp i d entify a nd critical l y as s e ss research o p p ortuniti e s a nd to p l ay a s u p p ortive r ole in the e xecu t ion of evid e n ce generation p l ans t o e n ha n ce the value of our p r od u c t s in a rea l - w orld s et t ing Reco g nize record and share ins i ghts that deepen o ur underst an ding of the n ee d s of patients, co n su m ers, r egulat o rs, pa yers, a n d h e althc a re p ro v iders a n d proacti v ely co n tribute t o war d s identi f y i ng u n met needs. Maintain ef fe ctive and ap p ro p riate co m munica t ion a mong inte r nal stak e holde r s ( Med i cal A f f airs coll e agues, Medical In f or m ation and C omme r cial O perati o ns) whi l e maintaini n g full compli a nce with relev a nt com p any, in d ustr y , legal a nd regula to ry requ i re m ents Dem o ns t rate operat i onal underst a nd i ng a n d r i sk mana g em e nt by ensur i ng ex c elle n ce in executi o n of all gover n a n ce pr o cesses. Engages e xternal st a ke h olders o n med i cal and s cientific inf o rmation ex c hange f o r t h e ther a pe u tic area during an on e- o n - one inter a ct i ons and group settin g s, exhib i ting excel l e n t sc i entific a n d c l in i cal kn o w l edge Uses strong kn o wledge of relevant d i sea s es a nd d i se a se m an a gement p rot o co l s, healt h ca r e e n v i ronm e nt and com p eti t ors t o articulate the medical a nd s c i enti f ic value of our prod u c t s with e x ter n al e x perts. Establi s h e s r ob u st, long-t e rm pe e r relat i onshi p s with Key Opinion Leade r s and other stakeho l der p artn e rs Acti v ely engages with ap pr opriate st a kehold e rs on m edical, clin i ca l , epidem i olog i c, a n d s c i enti f ic top i cs to advance their unde r stand i ng of the dise a se by sh a ring info r mati o n and a n swer in g qu e stio n s b as e d on a p pro v ed ma t er i al within Regu l atory guidel i n e s . Engag e s with appro p riate stakeho l ders to unde r sta n d the state of healthc a re p olicies and gui d elin e s as they rel a te to clini c al p ract i ces at a local, state, regional, fed e ra l , or national le v el. Uses defined syste m s to m ap, id enti fy , profile, a n d pr i orit i zes stak e holders i n line with the therapeu t ic ar e a med i cal plan a n d l o oks for op p or t unities to col l aborate and build a v alue b a sed partn e r ship addre s si n g the HC P s the ra peutic g oa l s. E f fecti v ely utiliz e s the S c i enti f ic En g a g ement M o del to plan t e rri t ory a n d indi v idual stakeho l der (Key Opini o n Lead e r s , paye r s, HCP etc.) medical st r ate g y and engagem e nt inter a ction pl a ns cons i stent with the Field Base Med i cal Acti v ity Plan and medical funct i on pri o riti e s. E f fecti v ely utiliz e s the S cien t if i c Enga ge ment Mo d el for a t t end i ng and e stabl i shing a Sanofi Med i cal pr e se n ce a t relevant scienti f ic cong re sses, sy m p o s i a as di r ect e d . Org a nizes e d ucati o nal m e etings o r loc a l scien t if i c a d v i sory bo a rds when r eq u es t ed. S upport sp ea ke r s tra i ning t o ensure con t inued s c i enti f ic supp o rt i n t he f iel d . Resp o n d s to unsol i cited r equest for medical infor m ation ass o cia t ed with su p por t e d pro d uc t s and dis e ase state a r ea. Gat h ers d ata and g en e rat e s ins i g h ts f rom s takeho l der in t era c tio n s a nd pro v ides fee d back to the or g aniz a tion Reco g nize a nd c ol l ect f e edba c k/re a ct i ons f r om m u lt i ple data s o u r c es and v ario u s stakeho l ders. R e co r d/r e port insights a n d informati o n a p pro p riately, using availab l e mechan i s m s and tools. Crit i cally and routinely eva l uate and d i s c ern fr o m the informati o n g a ined from p u b lished studi e s, a n d stakeho l d e r inter a ctio n s to develop key i n sigh t s that d ee p en o u r underst a ndi n g of the m arket ' s ne e ds and opin i o n s of ex t ernal stak e hol d ers and theref o re co n tribu t e to en h ancement of Sanofi ' s sci e nti f ic messa g es, pla n s, st r ategy, syste m s, and product dev e lopment. Maintain a waren e ss of a n d ass e ss e s e merg i ng evi d ence in d i se a se a rea to ed uca t e and e n ha n ce disc u s s i o n s with key st a kehol d ers. Collabor--- a tes effecti v e l y w i t h i nternal stakeh o lde r s Distr i bute re l evant scienti f ic a n d med i cal infor m ati o n and key e x t ernal i n sig h ts to internal stak e holders wh e n requested. Coll a bora t e, as di r ect e d, with Co m me r c i al O p e ratio n s, Bus i ness D evel o pment, Re g ulatory, etc. to facilita t e diligence re v iew s , med i cal and safe t y evaluation, prod u ct posit io ning, l ifecyc l e e v ide n ce pl a nnin g , and compli a n ce n e e d s. Contr i bute to the creation of material for inter n al and ex t ernal s t ake h old e rs wh er e appl i cable, following int e rnal Sanofi polici e s, and Federal a n d Na t ional Polici e s as appl i cable. Supp o r t s e v idenc e -ge n e ration a cti v i t ies b y aid i n g in data a c quis i tion a n d identif y ing oppor t unit ie s for fu r ther data c ol l ect i on cl i nical or in v estigat o r-led Monito r s d i se a se ep id emiology a nd provi d es sup p or t , incl u ding pr otocol develop m en t , when n e e d ed on vario u s t y pes of studi e s: l ong- t erm surveil la nc e , compl i a n ce, pharm a cov i g i lance, and e f fecti v en e ss s t udi e s Identi f ies da t a coll e ction opportuni t i e s duri n g st a kehold e r inte ra ctio n s and repor t s these u sing a pprov e d p r oce s ses. Maintai n s aware n ess of cl i nical trial a ctiv i ty within ter r itory and su g ges t s clin i cal tria l s sites a s r eq u este d . Resp o n d s to unsolicit e d requ e sts r eg a rd i ng inter e st in investigat o r spo n so r ed st u dies (IS S ), and s u ppor t s I S S submi s sio n s th r ough a ppro p r iate internal p roce s se s . Co n te x t of t he j ob/ m ajor chal l enges Able to op er ate ind e pe nd ently (with m inimal sup e r v ision) a n d n aviga t e co m plex re g ulat o ry Enviro n men t in person a n d v ia digi t al c hannels f rom remote (no n- of f ice b a se d ) enviro n ment. Poss i ble s u b stantial trave l : nationally and inter n atio n all y . E f fecti v ely mediate KOL ' s c o mplex a n d controv e r s i al opinions vs; co r pora t e policy d e ci s i o ns ensuri n g K OL relatio n shi p s / medical stra t egy are not n egati v ely impacte d . Ens u res r e g u latory bo u nd a ries re n o n - promo t ional ac t i v it i es are re s pect e d v i s - -- - v i s co m me r c i al partn e r s. Scope of Role / Output Mana g e a b a se of regional s t ake h old e r s ; developi n g a nd maintaini n g stakeho l der e ngagement t r acking d ata b ase. Plan da y - t o -d ay interacti o n s, includ i ng disc u s s i on p oints in acc o rda n ce with Medical A f fairs strateg y , e s t ablishing a freq u e n cy of inter a ctio n s per st a ke h o l der per year to e n su r e t hat obj e ctives a r e m et . Acc o untabili t y for the South Mid-Atlantic region/US level with rep o rting to Medical A f f airs E xecutes on defined KOL territ o ry strat e gy that is targeted to addr e ss dive r se st a ke h old e r ne e ds (pay e rs, pati e nts, KOLs, H CP etc . ) a n d is alig n ed with comp a ny ob j ecti v e s . Devel o ps rel e vant territ o ry engagem e nt pla n s in li n e with the m ed i cal strat e gy a nd sup p or t s the team's m e dical plan ex e cu t ion. Uses a ppro v ed scienti f ic data dur i ng KOL inter a ct i ons to adva n ce the un d erstand i ng of the therapeu t ic ar ea. Qual i fic a tio n s Education Ad v anc e d d e gree in a t e chnical, scienti f i c or m e dical f ield ( M D, PhD, Pharm D , ) prefe r red, o r other Relev a nt Life Scie n ces D e gree (RN/M S ) with Rare Disease S p e cialty requ i red. Exper i en c e P rev i o u s pharm a ceut i cal i nd u stry expe r ience pref e rred. Previous MSL experience strongly preferred. Rare Disease or Nephrology experience desired. Clear unde r standi n g of medical p r a ct i ce, clini c al d e c i s i on mak i ng a n d healthcare syste m s rela t ed to patient care. Abili t y to interpret key scie n ti f ic data and trans l ate this informati o n to meet educational and res e ar c h needs. Dem o ns t rat e d ability to addr e ss e d u cat i onal a n d re s earch n e e d s through deli v ery of cut t ing edge s c i enti f ic/evi d enced b a sed data. Un d erstand t he d e sign a n d e x ecuti o n o f rese ar ch st u dies. E x emplary com m un i cation and pre s enta t ion s kills. E x perie n ce in working o n mult i -d i s c i pli n ary teams a n d manag i ng s i gnific a nt volume of proj e c t s. Skills/Knowledge Acti v ely listens to others and is adept at confidently stating expert opinion w hile resp e cti n g the posit io ns of o thers - can exert diplo m acy while st a ndi n g f irm on a p o sition. Utiliz e s ef f ect i ve, profe s sional com m un i ca t ions to cult i va t e strong w ork i ng re l ati o nsh i ps with i n ternal and ex t er n al coll e agues, fle x ible in own appro a ch t o p eople a nd si t uatio n s . Skillfully plans, priorit i zes, a nd exe c utes mult i ple r e spons i bilit i es a n d proj e ct s . Dem o ns t rat e s ef f ecti v e le a dership s k il l s (by example and thr o ugh accompl i sh m ents), steps f or w ard to handle ch a lleng e s within sc o pe of au t horit y . De e p unders t anding and know l edge of local regula t i o ns and cod e s of practice for pharm a ceu t ical i nd u stry, in particu l ar a s t h ey apply to the no n - promo t ional a ctiv i ties of t his ro l e . Dem o ns t rat e s sci e nti f ic e x perti s e - sta y s a b re a st of data, treatm e nt tren d s, a n d n e w info r m ation in the prof e s s i o n and ability to articulate ther a peut i c knowl e dge a n d translate e x pert feed b ack into appro p riate i n sigh t s. K nowl e dge of relevant h ea lthcare s y st e ms, the evol v ing med i cal l an d scape, re gulatory a nd payer enviro n ment, publ i c health and in d ustry t ren d s . Profici e ncy in digi t al t ool s . Worki n g k no wledge of English a s a s econd la n guag e . Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law. The salary range for this position is $175,000-$205,000. In addition to sales incentive (role may my eligible for long term incentive depending on level and performance); all compensation will be determined commensurate with demonstrated experience. Employees may be eligible to participate in Company employee benefit programs. Additional benefits information can be found through the link, www.benefits.sanofiusallwell.com This position is eligible for a company car through the Company's FLEET program. As a healthcare company and a vaccine manufacturer, Sanofi has an important responsibility to protect individual and public health. All US based roles require individuals to be fully vaccinated against COVID-19 as part of your job responsibilities. According to the CDC, an individual is considered to be "fully vaccinated" fourteen (14) days after receiving (a) the second dose of the Moderna or Pfizer vaccine, or (b) the single dose of the J&J vaccine. Fully vaccinated, for new Sanofi employees, is to be fully vaccinated 14 DAYS PRIOR TO START DATE. Candidates must complete all fleet safety training and must maintain an acceptable driving record regarding accidents and incidents. GD-SG LI-GZ At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all. This employer is a corporate member of myGwork - LGBTQ professionals, the business community for LGBTQ professionals, students, inclusive employers & anyone who believes in workplace equality.

Keywords: myGwork, Denver , Medical Science Liaison - Rare Disease - Central West US, Other , Denver, Colorado